Gregory Gene Freitag

Gregory Gene Freitag, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Axogen, Inc. and PDS Biotechnology Corp. In total, 16 filings cover trades dated from 26 May 2021 to 28 February 2025.

Both buying and selling appear: 2 purchases worth €65k, against 7 sales worth €986k. Taken together, the sales exceed the purchases by €921k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 6 option exercises. So far in 2025, the count stands at 1 purchase and no sales.

The record was last updated on 3 March 2025 with an open-market purchase (€24k) in PDS Biotechnology Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.